# Right to Left Cardiac Shunt Detection

> **NCT01773252** · PHASE3 · TERMINATED · sponsor: **Cardiox Corporation** · enrollment: 141 (actual)

## Conditions studied

- Right to Left Shunt
- Patent Foramen Ovale
- Atrial Septal Defect

## Interventions

- **DEVICE:** Flow Detection System

## Key facts

- **NCT ID:** NCT01773252
- **Lead sponsor:** Cardiox Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2015-10
- **Final completion:** 2015-11
- **Target enrollment:** 141 (ACTUAL)
- **Why stopped:** Business decision to perform a market withdrawal of the product
- **Last updated:** 2015-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01773252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01773252, "Right to Left Cardiac Shunt Detection". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01773252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*